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Within the period of 1996 2CO4, 36 patients >16 years of age, suffering from Oy slic 
Fibrosis (CF) were examined ha our laboratory on a routine basis. Microbiology 
testing included: quantitative sputum cultures on common media, identification by 
API systems mad the automated s3,slem Vitek II, Biomerieaux France as wel l  as 
susceptibility testing by Kirby Bauer method and also by Vitek II, B iomerieaux 
France . Serum. t~aeruginosa anti exotoxinA, anti elastase mad anti alkal ine 
protease antibodies were detected for 28 of our patients by Elisa, using a 
commercial kit (antiPseudomotu~s aeruginosa IgG EIA Germany). Titers of 
> 1:500 were considered positive, whi le  >I:ICCCO indicative for non reversible 
t~ aeruginosa infection. Isolations included 182 strains P .aeruginosa, 33 S. aureus, 
32 H. infIuet~ae, 7 S. pneumoniae nd 1 S. maItophilia, t~aeruginosa susceptibility 
testing showed that 26,4% of isolates were resistant o Ticarcillin, 21,4% to 
Piperacill in, 14,8% to Ticarcil l in/clavulanic a id, 15,9% to Tobramycin, 15,9% to 
Aztreonam, 9% to Imipenem, 28% to Ceft azidine and 11% to Ciprofloxacin. None 
of S. aureus and S. pneumoniae strains were resistant to Oxacil l in, whi le  15,6% of 
H. influet~ae isolates were [3 lactamase(+). Serology testing showed that a 
progressive increase of anti exotoxin A, anti elastase and anti alkal ine protease 
antibodies confirmed a deterioration of patients' cl inical status. 
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CF has a tmique set of pathogens that are frequently acquired ha an age<lependent 
sequence. The aim of this study is to describe the age specific frequency of bacteria 
in the sputum of pediatric patients with CE 
From the 104 CF patients trader 18yo in Rio de Janeiro, 76(73%) were included. 
Each patient had a sputum sample cultured uring a routine visit from May to July/ 
2CO3. The patients were classified into 4 age groups: trader 2yo(n~ ), 2 5 yo(n 25), 
6 12yo(n 30) mad 13 17yo(n 14). 
The median age was 80too (min6/max2CO). ha the age group trader 2yo none culture 
had normal flora, Pa was present in sputum of the 7 patients. (ha the next group the 
cultures howed Sa in 11/25; Hi in 2/25; Pa in 14/25 and Be complex (Bcc) in 1/25. 
In theth i rdgrouptheexamswerepos i t i ve for :Sa  l l ; Pa  12 andBcc 4. And in the  
last one: SaM; Pa-7 and Bee 2. In 8/40 Pa positive cultures, 2 phenotypes were 
isolated. From the 7 Pa identified in the first group, 4(57,1%) were mucoid, whi le  
4/17(23,5%), 8/15(53,3%) and 5/9(55,5%) also were in the 2 ~, 3 ~d and 4 t~ group 
respectively. 
The number of patients with Hi and under 2yo with Sa was less than the xpected. 
Positive cultures for Pa had higher f equencies (40 1CO%), especially in the group 
under 2yo.The mucoid Pa was more frequent han the nonmucoid one, except for 
the 2 5yo group. Bcc was isolated in all groups except for the first one, mad its 
frequency raised significantly after the age of 6yo. 
The high frequency of mucoid Pa ha childhood is reason for concern. The isolation 
of t~aeruginosa and B.cepacia complex in children under 2yo and 5yo respectively, 
points to the possibility that CP diagnosis is being made mainly on the most 
clinically severe patients. 
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Chronic infection of CF airways contributes to ltmg damage, the main cause of 
morbidity and mortality in CF. The prevalence of pathogens is different between 
centers mad age groups The identification and knowledge of the prevalence of these 
pathogens is relevant for planning and the development of therapeutic strategies, 
including infection control practices. A im:  to describe the prevalence by age group 
of the pathogens isolated in CF patients of HCPA. Methods: all samples from 179 
patients between Ju ly/2002 and December/2CO3 were  analysed including 
spontaneous putum, oropharingeal swabs, orotracheal aspirates and BAL  We 
divided in 6 age groups: 02 ,  3 5, (~10, 11 15, 1(~20 and > 21 years. Results: 19 
patients between 0 2; 26 from 3 5; 44 from (~10; 41 from 11 15; 24 from 1(~20 
and 25 older than 21 years. Paeruginosa was identified ha 57.9%, 69.2%, 54.5%, 
63.4%, 79.2% and 80.0%, respectively. S.aureus ha 78.9%, 73.1%, 77.3%, 82.9%, 
83.3%. B.cepacia in 5.3%, 15.4%, 13.6%, 12.2%, 29.2% mad 8.0%. HaerrmphiIus 
sp. ha 21.0%, 15.4%, 29.5%, 17.1%, 8.3% and 12.0%. S.ma#ophiIia h 31.2%, 
23.1%, 20.4%, 17.1%, 20.8% and 8.0%. AlcaIigenes sp in 10.5%, 23.1%, 22.7%, 
29.3%, 25.0% and 4.0%. KlebsieIla sp in 42.1%, 26.9%, 6.8%, 12.2%, 16.7% and 
8.0%. F~coli ha 31.6%, 11.5%, 2.3%, 4.9%, 8.3% and 8.0%. Enterobacter ha36.8%, 
19.2%, 9.1%, 19.5%, 8.3% and 20.0%. Conclusions: We found an early acquisition 
of S.aureus and t~aeruginosa even ha recently diagnosed. Also we found a high 
prevalence of B.cepacia. These results are rather wort3,ing and they have alerted us 
to review the preventive infection strategies at HCPA CF Center. 
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We studied the prevalence and clinical relevance ofA. Xylosoxidans colonisation in 
140 patients. Identification was done using the RLPP DNA technique. Each A. 
Xylosoxidans colonised patient was compared to a control patient, matched for age 
(+ 1 year), gender and Pseudommw~s colonisation. 
The prevalence in our CF centre was 6% compared to 2.3% in the literature. 8
patients were colonised by A. Xylosoxidans (at least hree positive cultures per 
year), they had a median age of 20 years (range 11 27) and a mean colonisation 
period of 1.5 years (+ 0.9). 
At  the moment of the first positive culture we found significantly lower Bhal la 
scores (11 + 3 16 + 3, p<.CO2), lower BrasBeld scores (14 + 3 18 + 3, p<.019), 
lower FVC values (70% + 22 94% + 12, p<.017) and lower FEV 1 values (55% + 
32 78%+23,  p .123) ,a l thoughthelatterd idnotreachsigni f icance.  Therewasno  
significant difference in BMI  (18,7 + 3 19,6 + 3, p 0.8). Over the study period A. 
Xylosoxidans colonised patients did have more need for intravenous antibiotic 
treatment courses (19 5, p<.CO1), nevertheless there was no significant difference 
in lung function decline. 
The prevalence in our centre was higher compared to the scarce literature data, 
probably because of the use of DNA f inger printing techniques. Relying on routine 
laboratory analysis the prevalence of A. Xylosoxidans infection or colonisation 
seems tmderestimated. Mostly older patients, with more pronotmced lung damage 
and lower lung fimction values have positive cultures. Data on the post acquisition 
morbidity suggest a higher need for intravenous antibiotic treatment courses. No 
faster decline in lung function was observed in A. Xylosoxidans positive patients. 
